Show simple item record

dc.contributor.authorDai, Weiwei
dc.contributor.authorUsami, Yoshiko
dc.contributor.authorWu, Yuanfei
dc.contributor.authorGottlinger, Heinrich G.
dc.date2022-08-11T08:09:49.000
dc.date.accessioned2022-08-23T16:44:44Z
dc.date.available2022-08-23T16:44:44Z
dc.date.issued2018-01-23
dc.date.submitted2018-04-18
dc.identifier.citation<p>Cell Rep. 2018 Jan 23;22(4):869-875. doi: 10.1016/j.celrep.2017.12.082. Epub 2018 Jan 28. <a href="https://doi.org/10.1016/j.celrep.2017.12.082">Link to article on publisher's site</a></p>
dc.identifier.issn2211-1247 (Electronic)
dc.identifier.doi10.1016/j.celrep.2017.12.082
dc.identifier.pmid29386131
dc.identifier.urihttp://hdl.handle.net/20.500.14038/40558
dc.description.abstractWe recently identified the multipass transmembrane protein SERINC5 as an antiviral protein that can potently inhibit HIV-1 infectivity and is counteracted by HIV-1 Nef. We now report that the anti-HIV-1 activity, but not the sensitivity to Nef, is conserved among vertebrate SERINC5 proteins. However, a Nef-resistant SERINC5 became Nef sensitive when its intracellular loop 4 (ICL4) was replaced by that of Nef-sensitive human SERINC5. Conversely, human SERINC5 became resistant to Nef when its ICL4 was replaced by that of a Nef-resistant SERINC5. In general, ICL4 regions from SERINCs that exhibited resistance to a given Nef conferred resistance to the same Nef when transferred to a sensitive SERINC, and vice versa. Our results establish that human SERINC5 can be modified to restrict HIV-1 infectivity even in the presence of Nef.
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=29386131&dopt=Abstract">Link to Article in PubMed</a></p>
dc.rightsCopyright 2017 The Authors. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectHIV-1
dc.subjectNef
dc.subjectSERINC5
dc.subjectrestriction factor
dc.subjectBiochemistry
dc.subjectImmunology of Infectious Disease
dc.subjectMolecular Biology
dc.subjectVirology
dc.subjectViruses
dc.titleA Long Cytoplasmic Loop Governs the Sensitivity of the Anti-viral Host Protein SERINC5 to HIV-1 Nef
dc.typeJournal Article
dc.source.journaltitleCell reports
dc.source.volume22
dc.source.issue4
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=4374&amp;context=oapubs&amp;unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/oapubs/3363
dc.identifier.contextkey11980776
refterms.dateFOA2022-08-23T16:44:44Z
html.description.abstract<p>We recently identified the multipass transmembrane protein SERINC5 as an antiviral protein that can potently inhibit HIV-1 infectivity and is counteracted by HIV-1 Nef. We now report that the anti-HIV-1 activity, but not the sensitivity to Nef, is conserved among vertebrate SERINC5 proteins. However, a Nef-resistant SERINC5 became Nef sensitive when its intracellular loop 4 (ICL4) was replaced by that of Nef-sensitive human SERINC5. Conversely, human SERINC5 became resistant to Nef when its ICL4 was replaced by that of a Nef-resistant SERINC5. In general, ICL4 regions from SERINCs that exhibited resistance to a given Nef conferred resistance to the same Nef when transferred to a sensitive SERINC, and vice versa. Our results establish that human SERINC5 can be modified to restrict HIV-1 infectivity even in the presence of Nef.</p>
dc.identifier.submissionpathoapubs/3363
dc.contributor.departmentDepartment of Molecular, Cell and Cancer Biology
dc.source.pages869-875


Files in this item

Thumbnail
Name:
Publisher version
Thumbnail
Name:
1_s2.0_S2211124717319198_main.pdf
Size:
1.438Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Copyright 2017 The Authors. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Except where otherwise noted, this item's license is described as Copyright 2017 The Authors. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).